RS20130044A1 - Pharmaceutical composition for psoriasis treatment - Google Patents

Pharmaceutical composition for psoriasis treatment

Info

Publication number
RS20130044A1
RS20130044A1 RS20130044A RSP20130044A RS20130044A1 RS 20130044 A1 RS20130044 A1 RS 20130044A1 RS 20130044 A RS20130044 A RS 20130044A RS P20130044 A RSP20130044 A RS P20130044A RS 20130044 A1 RS20130044 A1 RS 20130044A1
Authority
RS
Serbia
Prior art keywords
composition
pharmaceutical composition
betamethasone
psoriasis treatment
substances
Prior art date
Application number
RS20130044A
Other languages
Serbian (sr)
Inventor
Nikola Mirko Švrakić
Original Assignee
Nikola Mirko Švrakić
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikola Mirko Švrakić filed Critical Nikola Mirko Švrakić
Priority to RS20130044A priority Critical patent/RS20130044A1/en
Publication of RS20130044A1 publication Critical patent/RS20130044A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Invention herewith described refers to the invention of the pharmaceutical composition and the method of preparing of the composition in the form of a spray for the psoriasis treatment. Liquefaction of the composition makes the absorption easier and faster than the composition in the form of ointment, and allows a deeper penetration into the skin and later relapses. The composition is a mixture of five substances, namely: the betamethasone of microcrystalline structure, ethyl alcohol, sodium lauryl sulphate, isopropyl myristate, and zinc pyrithione. The method of preparing the pharmaceutical composition is performed by dissolving betamethasone microcrystalline structure in ethyl alcohol and separately mixing sodium lauryl sulphate, isopropyl myristate, and zinc pyrithione. Finally, the solution of betamethasone and the mixture of other substances are mixed together.
RS20130044A 2013-02-07 2013-02-07 Pharmaceutical composition for psoriasis treatment RS20130044A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RS20130044A RS20130044A1 (en) 2013-02-07 2013-02-07 Pharmaceutical composition for psoriasis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RS20130044A RS20130044A1 (en) 2013-02-07 2013-02-07 Pharmaceutical composition for psoriasis treatment

Publications (1)

Publication Number Publication Date
RS20130044A1 true RS20130044A1 (en) 2014-08-29

Family

ID=51584468

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20130044A RS20130044A1 (en) 2013-02-07 2013-02-07 Pharmaceutical composition for psoriasis treatment

Country Status (1)

Country Link
RS (1) RS20130044A1 (en)

Similar Documents

Publication Publication Date Title
BR112018000734A2 (en) retinoic topical compositions
MY196418A (en) Therapeutically Active Compounds and Their Methods of use
IN2014MN01755A (en)
PH12014501561A1 (en) Therapeutically active compounds and their methods of use
NZ716033A (en) Treatment of papulopustular rosacea with ivermectin
WO2013136192A3 (en) Use of tetracycline compositions for wound treatment and skin restoration
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
EA201590520A1 (en) PHARMACEUTICAL COMPOSITION WITH COATING CONTAINING REGORAPHENIB
WO2015003355A3 (en) Therapeutically active compounds and their methods of use
MX2019014952A (en) Compositions for skin exfoliation and use thereof.
MX2016004741A (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent.
MX2015013148A (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics.
BR112016029012A2 (en) method of treating non-small cell lung cancer and / or small cell lung cancer using thienotriazolodiazepine compounds
MX348418B (en) Ocular composition containing bromfenac with increased bioavailability.
RS20130044A1 (en) Pharmaceutical composition for psoriasis treatment
BR112016017496A2 (en) COMPOSITION FOR ACCELERATING PENETRATION THROUGH THE SKIN, PREPARATION FOR TRANSDERMAL ADMINISTRATION AND SKIN PATTER PREPARATION
TW201613599A (en) Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease
WO2014150959A3 (en) Method and products for enhancing cellular uptake of drug and dietary supplements
UA83437U (en) Bahisept drug composition as solution for antiseptic preparation of wounds surfaces, mucosas and skin and hair coat of animals
UA88421U (en) Fusipan-derma pharmaceutical composition for treating acne stages i-ii
MX2015016930A (en) Use and pharmaceutical compositions containing coordination compounds with redox activity that is coordinated with the cellular dna.
MX2012001667A (en) Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.
UA61631U (en) Experimental simulation method for pancreatitis